President Donald Trump’s December 18th executive order moving cannabis from Schedule I to Schedule III marks a major federal policy shift that expands medical recognition and research access without fully legalizing the drug, and it sets the stage for significant growth and professionalization in cannabis cultivation. This growth is likely to increase demand for high‑performance, [...]














